Keeping Track: Exelixis, Sanofi Submit NDAs While AstraZeneca, Actelion Collect Approvals
Executive Summary
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Real-World Database Studies: Prepare For A Long Journey, IQVIA Advises
Rigorous planning and a multidisciplinary team including database experts and healthcare specialists with local knowledge are vital to effective real-world evidence, white paper shows.
Keeping Track: Submissions From Alkermes, Samsung Bioepis; BTDs for Orphazyme and Kiniksa
The latest submission and expedited review program news and highlights from our US FDA Performance Tracker.
Keeping Track Of Review Designations: BTDs For X4, F2G, And BMS; Another QIDP For Allergan
The latest news about products accepted into US FDA expedited review programs.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: